Search results
'Irreversible, but...': What is NATO's plan for Ukraine beyond just words?
EuroNews· 5 days agoWhile gathering in Washington to celebrate the alliance's 75th anniversary, NATO's heads of state...
Exploring Three Undervalued Small Caps In Canada With Insider Buying
Simply Wall St. via Yahoo Finance UK· 5 days agoAs central banks like the Bank of Canada (BoC) initiate rate cuts in response to softening economic...
Lauren Riley: 'For net-zero to take off, we need a breakthrough in sustainable aviation fuel'
Reuters· 1 day agoBy most industry metrics, United Airlines’s environment strategy is flying high. Since the...
World’s first commercial hydrogen ferry is taking passengers for free
EuroNews· 2 days agoThe 21-metre catamaran called the MV Sea Change will transport up to 75 passengers along the...
Fantasy football breakouts for all 32 NFL teams, led by Bijan Robinson, Jameson Williams
New York Times· 2 days agoPerhaps it’s a highly touted draft pick who is now ready for the spotlight, or a journeyman veteran who landed in an ideal situation. With fantasy draft season drawing closer, The Athletic’s ...
Exclusive: India's Modi delays privatisation plans
Reuters· 5 days ago, opens new tab programme that has struggled to take off, government sources said. The programme to privatise a major portion of India's lumbering $600...
London open: FTSE nudges up after stronger-than-expected UK GDP
ShareCast· 6 days agoLondon stocks nudged higher in early trade on Thursday following better-than-expected UK GDP data,...
Glycostem launches pivotal oncology trial with evolved naked natural killer cells
Nature· 5 days agoGlycostem’s pivotal trial is planned to start in late 2020 and will involve five European countries, eight clinical trial centers and 33 patients with minimal residual disease (MRD) positive ...
JPY intervention amid volatility?
The Forex Market· 5 days agoAsia market update: Tech down, Main Street up; JPY Intervention amid volatility?; CN budget surplus soars; Pres Biden drama continues; Focus on US Jun...
Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market
Reuters· 2 days agoDemocratic U.S. Senate aides will meet with Novo Nordisk executives on Tuesday to discuss fallout...